A recent validation study by the Contra Costa County Public Health Laboratory (CCPHL) has demonstrated the potential of Techcyte’s AI-assisted ova and parasite (O&P) workflow in enhancing laboratory efficiency. The study, which has been accepted for presentation at the APHL 2026 Annual Conference, evaluated the integration of Techcyte’s parasitology suite with an automated whole slide imager from Pramana, now known as Evident. The results indicated a significant improvement in operational processes, showcasing an impressive 97% accuracy, 98% sensitivity, and 97% specificity in analyzing 549 patient samples.
Conventional O&P testing methods often require labor-intensive manual microscopy and specialized expertise, posing challenges amid rising specimen volumes and staffing constraints. To address these issues, CCPHL explored the use of an AI-assisted digital workflow. The study encompassed both newly received and archived patient specimens, comparing the AI-enhanced results with traditional microscopy. The findings suggest that incorporating AI technology not only reduces turnaround times but also alleviates staff fatigue, paving the way for more efficient laboratory operations without compromising diagnostic standards.
Despite the introduction of AI into the workflow, final confirmation of positive cases is still performed using traditional light microscopy. This ensures that while AI aids in the initial screening process, established diagnostic practices remain intact. The study’s authors emphasize the potential of AI integration in public health laboratories to mitigate workforce shortages, maintaining high standards in diagnostic accuracy and operational efficiency.
Tyler Rippy, Account Executive at Techcyte, expressed enthusiasm for the collaboration with CCPHL, highlighting the study as a pivotal step in advancing AI-assisted workflows in parasitology labs. Techcyte’s comprehensive digital parasitology solution accommodates multiple staining methods within a unified workflow, aiming to transform pathology practices through digital innovation.
Techcyte, founded in 2013, is dedicated to digitizing lab workflows and enhancing diagnostic testing accuracy through its unified pathology platform. The company is set to showcase its AI-powered digital pathology solutions at the APHL 2026 Annual Conference in Baltimore from May 4–7, 2026. Visitors can learn more about their offerings at Booth 201. For further details, Techcyte encourages visiting their website.
